v3.26.1
STOCKHOLDERS’ EQUITY - Narrative (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Sep. 18, 2025
USD ($)
$ / shares
Jul. 01, 2025
Oct. 18, 2024
USD ($)
shares
Oct. 02, 2024
USD ($)
shares
Jun. 12, 2024
shares
Feb. 21, 2024
USD ($)
$ / shares
shares
Feb. 15, 2024
Mar. 31, 2026
$ / shares
shares
Jan. 12, 2026
$ / shares
shares
Dec. 31, 2025
$ / shares
Apr. 16, 2025
shares
Jul. 26, 2024
USD ($)
Jun. 11, 2024
shares
Subsidiary, Sale of Stock [Line Items]                          
Stock split, conversion ratio   0.1         0.11            
Common stock, increase (decrease) in capital shares reserved for future issuance         150,000                
Common stock, capital shares reserved for future issuance (in shares)         194,444     354,497     2,400,000   44,444
Common stock, par value (in dollars per share) | $ / shares               $ 0.0001 $ 0.0001 $ 0.0001      
Stock options | Two Thousand Twenty Three Plan                          
Subsidiary, Sale of Stock [Line Items]                          
Stock options expiration period               10 years          
Horizon Warrants                          
Subsidiary, Sale of Stock [Line Items]                          
Number of securities called by warrants (in shares)                 65,488        
Warrant exercise price (in dollars per share) | $ / shares                 $ 27.49        
Warrant term                 10 years        
IPO                          
Subsidiary, Sale of Stock [Line Items]                          
Sale of stock, number of shares issued in transaction (in shares)           110,000              
Sale of preferred stock price per share (in dollars per share) | $ / shares           $ 60.00              
Proceeds from issuance initial public offering | $           $ 5,900              
Offering cost, expense | $           $ 900              
IPO | Warrants To Purchase Common Shares Issued                          
Subsidiary, Sale of Stock [Line Items]                          
Number of securities called by warrants (in shares)           5,500              
Warrant exercise price (in dollars per share) | $ / shares $ 33.31         $ 75.00              
Warrant, period following commencement date, exercisable           180 days              
Fair value adjustment of warrants | $ $ 31                        
CEF Purchase Agreement                          
Subsidiary, Sale of Stock [Line Items]                          
Sale of stock, number of shares issued in transaction (in shares)     7,965 7,632                  
Sale of stock, authorized amount | $                       $ 30,000  
Sale of stock, consideration received on transaction | $     $ 63 $ 46